Correlation Between BIONTECH and UBS Group
Can any of the company-specific risk be diversified away by investing in both BIONTECH and UBS Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BIONTECH and UBS Group into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BIONTECH SE DRN and UBS Group AG, you can compare the effects of market volatilities on BIONTECH and UBS Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BIONTECH with a short position of UBS Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of BIONTECH and UBS Group.
Diversification Opportunities for BIONTECH and UBS Group
Very weak diversification
The 3 months correlation between BIONTECH and UBS is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding BIONTECH SE DRN and UBS Group AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UBS Group AG and BIONTECH is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BIONTECH SE DRN are associated (or correlated) with UBS Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UBS Group AG has no effect on the direction of BIONTECH i.e., BIONTECH and UBS Group go up and down completely randomly.
Pair Corralation between BIONTECH and UBS Group
Assuming the 90 days trading horizon BIONTECH is expected to generate 1.0 times less return on investment than UBS Group. In addition to that, BIONTECH is 1.86 times more volatile than UBS Group AG. It trades about 0.07 of its total potential returns per unit of risk. UBS Group AG is currently generating about 0.13 per unit of volatility. If you would invest 16,810 in UBS Group AG on September 28, 2024 and sell it today you would earn a total of 1,928 from holding UBS Group AG or generate 11.47% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
BIONTECH SE DRN vs. UBS Group AG
Performance |
Timeline |
BIONTECH SE DRN |
UBS Group AG |
BIONTECH and UBS Group Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BIONTECH and UBS Group
The main advantage of trading using opposite BIONTECH and UBS Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BIONTECH position performs unexpectedly, UBS Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UBS Group will offset losses from the drop in UBS Group's long position.BIONTECH vs. Novo Nordisk AS | BIONTECH vs. Vertex Pharmaceuticals Incorporated | BIONTECH vs. Moderna | BIONTECH vs. BeiGene |
UBS Group vs. JPMorgan Chase Co | UBS Group vs. N1RG34 | UBS Group vs. Aeris Indstria e | UBS Group vs. N1WG34 |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |